Category: 31. Quality of Care and Outcomes Assessment Background: Lower extremity peripheral artery disease (LEPAD) is a common syndrome that afflicts many individuals and leads to significant morbidity. Appropriate treatment of high risk individuals, per recommendations outlined in the American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines for the Management of Peripheral Artery Disease (PAD) (JACC, 2006), consists of treatment with hydroxymethyl glutaryl (HMG) coenzyme-A reductase inhibitors (statins), aspirin, and ACE-inhibitors. Outpatient cardiology practices often take care of high risk patients and thus have the unique opportunity to treat LEPAD.
